Akt/mTOR pathway-mediated CCNA1 regulation of radiotherapy resistance in nasopharyngeal carcinoma

Key Points

• CCNA1 regulation linked with radiotherapy resistance in nasopharyngeal carcinoma shows significant implications.
• Key evidence indicates that alterations in the Akt/mTOR pathway directly influence CCNA1 levels.
• Observational analysis across various treatment cohorts presents data on resistance mechanisms and patient outcomes.
• Highlights the need for further exploration of the Akt/mTOR pathway in overcoming treatment resistance.